{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:19:05Z","timestamp":1780485545721,"version":"3.54.1"},"reference-count":37,"publisher":"Japan Atherosclerosis Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2022,9,1]]},"DOI":"10.5551\/jat.63044","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T22:09:27Z","timestamp":1632780567000},"page":"1285-1294","source":"Crossref","is-referenced-by-count":16,"title":["A Randomized, Double-Blind Comparison Study of Royal Jelly to Augment Vascular Endothelial Function in Healthy Volunteers"],"prefix":"10.5551","volume":"29","author":[{"given":"Koichiro","family":"Fujisue","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Sueta","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Arima","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Hirakawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Tabata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miwa","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenshi","family":"Yamanaga","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Hanatani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Hoshiyama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisanori","family":"Kanazawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Takashio","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Araki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Usuku","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taishi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Soejima","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kaikita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kawano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Division of Advanced Cardiovascular Therapeutics, Department of Cardiovascular Medicine, Kumamoto University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences and Center for Metabolic Regulation of Healthy Aging (CMHA), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Uchikado Y, Ikeda Y and Ohishi M: Current Understanding of the Role of Frailty in Cardiovascular Disease. Circ J, 2020; 84: 1903-1908","DOI":"10.1253\/circj.CJ-20-0594"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Akiyama E, Sugiyama S, Matsuzawa Y, Konishi M, Suzuki H, Nozaki T, Ohba K, Matsubara J, Maeda H, Horibata Y, Sakamoto K, Sugamura K, Yamamuro M, Sumida H, Kaikita K, Iwashita S, Matsui K, Kimura K, Umemura S and Ogawa H: Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction. J Am Coll Cardiol, 2012; 60: 1778-1786","DOI":"10.1016\/j.jacc.2012.07.036"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Fujisue K, Sugiyama S, Matsuzawa Y, Akiyama E, Sugamura K, Matsubara J, Kurokawa H, Maeda H, Hirata Y, Kusaka H, Yamamoto E, Iwashita S, Sumida H, Sakamoto K, Tsujita K, Kaikita K, Hokimoto S, Matsui K and Ogawa H: Prognostic Significance of Peripheral Microvascular Endothelial Dysfunction in Heart Failure With Reduced Left Ventricular Ejection Fraction. Circ J, 2015; 79: 2623-2631","DOI":"10.1253\/circj.CJ-15-0671"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Fujisue K, Sugiyama S, Ono T, Matsuzawa Y, Akiyama E, Sugamura K, Matsubara J, Kurokawa H, Kaikita K, Iwashita S, Sumida H, Hokimoto S, Oniki K, Nakagawa K, Matsui K and Ogawa H: Effects of endothelial dysfunction on residual platelet aggregability after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. Circ Cardiovasc Interv, 2013; 6: 452-459","DOI":"10.1161\/CIRCINTERVENTIONS.112.000278"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Matsuzawa Y, Sugiyama S, Sugamura K, Nozaki T, Ohba K, Konishi M, Matsubara J, Sumida H, Kaikita K, Kojima S, Nagayoshi Y, Yamamuro M, Izumiya Y, Iwashita S, Matsui K, Jinnouchi H, Kimura K, Umemura S and Ogawa H: Digital assessment of endothelial function and ischemic heart disease in women. J Am Coll Cardiol, 2010; 55: 1688-1696","DOI":"10.1016\/j.jacc.2009.10.073"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Matsuzawa Y, Sugiyama S, Sumida H, Sugamura K, Nozaki T, Ohba K, Matsubara J, Kurokawa H, Fujisue K, Konishi M, Akiyama E, Suzuki H, Nagayoshi Y, Yamamuro M, Sakamoto K, Iwashita S, Jinnouchi H, Taguri M, Morita S, Matsui K, Kimura K, Umemura S and Ogawa H: Peripheral endothelial function and cardiovascular events in high-risk patients. J Am Heart Assoc, 2013; 2: e000426","DOI":"10.1161\/JAHA.113.000426"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Matsubara J, Sugiyama S, Akiyama E, Iwashita S, Kurokawa H, Ohba K, Maeda H, Fujisue K, Yamamoto E, Kaikita K, Hokimoto S, Jinnouchi H and Ogawa H: Dipeptidyl peptidase-4 inhibitor, sitagliptin, improves endothelial dysfunction in association with its anti-inflammatory effects in patients with coronary artery disease and uncontrolled diabetes. Circ J, 2013; 77: 1337-1344","DOI":"10.1253\/circj.CJ-12-1168"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Prasad A, Tupas-Habib T, Schenke WH, Mincemoyer R, Panza JA, Waclawin MA, Ellahham S and Quyyumi AA: Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis. Circulation, 2000; 101: 2349-2354","DOI":"10.1161\/01.CIR.101.20.2349"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Prasad A, Halcox JP, Waclawiw MA and Quyyumi AA: Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis. J Am Coll Cardiol, 2001; 38: 1089-1095","DOI":"10.1016\/S0735-1097(01)01511-X"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Modena MG, Bonetti L, Coppi F, Bursi F and Rossi R: Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol, 2002; 40: 505-510","DOI":"10.1016\/S0735-1097(02)01976-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Gould KL, Martucci JP, Goldberg DI, Hess MJ, Edens RP, Latifi R and Dudrick SJ: Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium. Circulation, 1994; 89: 1530-1538","DOI":"10.1161\/01.CIR.89.4.1530"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Nakamura T, Uematsu M, Yoshizaki T, Kobayashi T, Watanabe Y and Kugiyama K: Improvement of endothelial dysfunction is mediated through reduction of remnant lipoprotein after statin therapy in patients with coronary artery disease. J Cardiol, 2020; 75: 270-274","DOI":"10.1016\/j.jjcc.2019.08.006"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Watadani R, Kotoh J, Sasaki D, Someya A, Matsumoto K and Maeda A: 10-Hydroxy-2-decenoic acid, a natural product, improves hyperglycemia and insulin resistance in obese\/diabetic KK-Ay mice, but does not prevent obesity. J Vet Med Sci, 2017; 79: 1596-1602","DOI":"10.1292\/jvms.17-0348"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Tokunaga KH, Yoshida C, Suzuki KM, Maruyama H, Futamura Y, Araki Y and Mishima S: Antihypertensive effect of peptides from royal jelly in spontaneously hypertensive rats. Biol Pharm Bull, 2004; 27: 189-192","DOI":"10.1248\/bpb.27.189"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Zamami Y, Takatori S, Goda M, Koyama T, Iwatani Y, Jin X, Takai-Doi S and Kawasaki H: Royal jelly ameliorates insulin resistance in fructose-drinking rats. Biol Pharm Bull, 2008; 31: 2103-2107","DOI":"10.1248\/bpb.31.2103"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Ozasa N, Morimoto T, Bao B, Shioi T and Kimura T: Effects of machine-assisted cycling on exercise capacity and endothelial function in elderly patients with heart failure. Circ J, 2012; 76: 1889-1894","DOI":"10.1253\/circj.CJ-11-1113"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Morita H, Ikeda T, Kajita K, Fujioka K, Mori I, Okada H, Uno Y and Ishizuka T: Effect of royal jelly ingestion for six months on healthy volunteers. Nutr J, 2012; 11: 77","DOI":"10.1186\/1475-2891-11-77"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Khoshpey B, Djazayeri S, Amiri F, Malek M, Hosseini AF, Hosseini S, Shidfar S and Shidfar F: Effect of Royal Jelly Intake on Serum Glucose, Apolipoprotein A-I (ApoA-I), Apolipoprotein B (ApoB) and ApoB\/ApoA-I Ratios in Patients with Type 2 Diabetes: A Randomized, Double-Blind Clinical Trial Study. Can J Diabetes, 2016; 40: 324-328","DOI":"10.1016\/j.jcjd.2016.01.003"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Pourmoradian S, Mahdavi R, Mobasseri M, Faramarzi E and Mobasseri M: Effects of royal jelly supplementation on glycemic control and oxidative stress factors in type 2 diabetic female: a randomized clinical trial. Chin J Integr Med, 2014; 20: 347-352","DOI":"10.1007\/s11655-014-1804-8"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Inoue S, Kawashima M, Hisamura R, Imada T, Izuta Y, Nakamura S, Ito M and Tsubota K: Clinical Evaluation of a Royal Jelly Supplementation for the Restoration of Dry Eye: A Prospective Randomized Double Blind Placebo Controlled Study and an Experimental Mouse Model. PLoS One, 2017; 12: e0169069","DOI":"10.1371\/journal.pone.0169069"},{"key":"21","unstructured":"21) Takenaka T: Chemical composition of royal jelly. Honeybee Science, 1982; 3: 69-74"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Bonetti PO, Barsness GW, Keelan PC, Schnell TI, Pumper GM, Kuvin JT, Schnall RP, Holmes DR, Higano ST and Lerman A: Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol, 2003; 41: 1761-1768","DOI":"10.1016\/S0735-1097(03)00329-2"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Liu J, Wang J, Jin Y, Roethig HJ and Unverdorben M: Variability of peripheral arterial tonometry in the measurement of endothelial function in healthy men. Clin Cardiol, 2009; 32: 700-704","DOI":"10.1002\/clc.20668"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Brant LC, Barreto SM, Passos VM and Ribeiro AL: Reproducibility of peripheral arterial tonometry for the assessment of endothelial function in adults. J Hypertens, 2013; 31: 1984-1990","DOI":"10.1097\/HJH.0b013e328362d913"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Nil M, Sch\u00e4fer D, Radtke T, Saner H, Wilhelm M and Eser P: Reproducibility of peripheral arterial tonometry measurements in male cardiovascular patients. Eur J Clin Invest, 2014; 44: 1065-1071","DOI":"10.1111\/eci.12341"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Sauder KA, West SG, McCrea CE, Campbell JM, Jenkins AL, Jenkins DJ and Kendall CW: Test-retest reliability of peripheral arterial tonometry in the metabolic syndrome. Diab Vasc Dis Res, 2014; 11: 201-207","DOI":"10.1177\/1479164114525971"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) McCrea CE, Skulas-Ray AC, Chow M and West SG: Test-retest reliability of pulse amplitude tonometry measures of vascular endothelial function: implications for clinical trial design. Vasc Med, 2012; 17: 29-36","DOI":"10.1177\/1358863X11433188"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Colhoun EH and Smith MV: Neurohormonal properties of royal jelly. Nature, 1960; 188: 854-855","DOI":"10.1038\/188854a0"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Wessler I, G\u00e4rtner HA, Michel-Schmidt R, Brochhausen C, Schmitz L, Anspach L, Gr\u00fcnewald B and Kirkpatrick CJ: Honeybees Produce Millimolar Concentrations of Non-Neuronal Acetylcholine for Breeding: Possible Adverse Effects of Neonicotinoids. PLoS One, 2016; 11: e0156886","DOI":"10.1371\/journal.pone.0156886"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Liang Y, Kagota S, Maruyama K, Oonishi Y, Miyauchi-Wakuda S, Ito Y, Yamada S and Shinozuka K: Royal jelly increases peripheral circulation by inducing vasorelaxation through nitric oxide production under healthy conditions. Biomed Pharmacother, 2018; 106: 1210-1219","DOI":"10.1016\/j.biopha.2018.07.047"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Sultana A, Nabi AH, Nasir UM, Maruyama H, Suzuki KM, Mishima S and Suzuki F: A dipeptide YY derived from royal jelly proteins inhibits renin activity. Int J Mol Med, 2008; 21: 677-681","DOI":"10.3892\/ijmm.21.6.677"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Kanbur M, Eraslan G, Beyaz L, Silici S, Liman BC, Altinordulu S and Atasever A: The effects of royal jelly on liver damage induced by paracetamol in mice. Exp Toxicol Pathol, 2009; 61: 123-132","DOI":"10.1016\/j.etp.2008.06.003"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, Romanelli AJ and Shulman GI: Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem, 2004; 279: 32345-32353","DOI":"10.1074\/jbc.M313478200"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Meshkani R and Adeli K: Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem, 2009; 42: 1331-1346","DOI":"10.1016\/j.clinbiochem.2009.05.018"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Byrne CD and Targher G: NAFLD: a multisystem disease. J Hepatol, 2015; 62: S47-64","DOI":"10.1016\/j.jhep.2014.12.012"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Targher G, Day CP and Bonora E: Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med, 2010; 363: 1341-1350","DOI":"10.1056\/NEJMra0912063"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Maleki V, Jafari-Vayghan H, Saleh-Ghadimi S, Adibian M, Kheirouri S and Alizadeh M: Effects of Royal jelly on metabolic variables in diabetes mellitus: A systematic review. Complement Ther Med, 2019; 43: 20-27","DOI":"10.1016\/j.ctim.2018.12.022"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/9\/29_63044\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T05:19:26Z","timestamp":1662182366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/9\/29_63044\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.63044","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]},"article-number":"63044"}}